Sean Keohane
Analyst · UBS. Your line is open
Sure. Yes, thank you. Thanks, Josh. Well, we certainly we’re very pleased to see the strength in Performance Chemicals. And I would say the drivers are really two main factors. One, of course, volume growth was strong, and so the operating leverage that comes from that is material. But I think, most importantly, what I would say the normalization of our product mix, which has been a significant drag for this business over the last four to six quarters, that has now normalized. And we would view that as sort of volumes having reconnected to underlying demand there. And so I’ll give a couple of examples. Certainly, the automotive sector is a very important one for this segment, where products typically in this sector are specified in and end up carrying good, strong margins. And while you’ve seen some growth and relative strength in auto production, a lot of our products, because the value chains are longer, really suffered from prolonged destocking. And even though the auto build’s numbers were looking pretty good, we weren’t seeing it yet in our demand as the lengthy value chain sort of worked out its inventory that has now reconnected. And so seeing that strong mix was certainly a big driver. And again, we think it’s reconnected. So that’s positive. I would say another key factor in the mix was semiconductors. So the CMP application, where we sell fumed silica, last year was a very, very weak quarter across that whole chain. And again, I think now inventories have worked their way out, and we’re seeing a reconnection there. And so good, strong margins in that application. And then finally, we have been underwriting a lot of new product growth in areas around infrastructure. So wire and cable, think about this as connecting offshore wind farms, things like this. Our products are used in applications like that, and those continue to do well and carry good, strong margins. So it’s really a mix return to normal, I would say, was a really big driver, along with the headline volume numbers. Now, in terms of how do we think about moving forward, I think, if we remain in and around these volume levels, we would expect the quarterly EBIT would be in the range of $45 million to $55 million per quarter, depending on the quarter. And specific quarters can be impacted by seasonal demand, product mix, and then the timing of when we do maintenance on our assets. That can have a significant impact here because the asset base is a little more concentrated than in Reinforcement Materials where we have a lot more plants. And so one or two plants down for maintenance, it kind of gets diluted in Reinforcement a little bit more so and Performance Chemicals can be a little more pronounced. So, these things can drive some quarterly variation. But I think as we sit here now, our best view would be sort of in and around that range of $45 million to $55 million per quarter, depending on some of those specific factors.